Additionally, ilimaquinone inhibits pyruvate dehydrogenase kinase 1 (PDK1), reducing aerobic glycolysis and depleting cellular ATP, which sensitizes cancer cells to apoptosis [30]. This evidence concerns the gene PDK1 and cancer.